Regulatory Approval Or License Win
Expected: OngoingHIGH confidence
What: ISM Approval: 1 of 10 projects
“SiCSem is among the 10 projects approved by Union Cabinet under the Indian Semiconductor Mission.”
Archean Chemical Industries Ltd: Why Is It Outperforming Nifty 500?
ActiveWeak9w Streak
In , Archean Chemical Industries Ltd (Chemicals - Inorganic) is outperforming Nifty 500 with +6.2% relative strength. Fundamentals: Weak. On a 9-week streak.
Archean Chemical Industries Ltd Key Facts
- PE Ratio
- 51.3x
- Market Cap
- ₹7,509 Cr
- PAT Growth YoY
- -50%
- Revenue Growth YoY
- +5%
- OPM
- 21.0%
- RS vs Nifty 500
- +6.2%
PE: At PeakDanger Bubble
What's Happening
⚠️PE rising despite falling earnings — price running ahead of reality
🌐FII stake increased 1.0% this quarter
🏛️DII accumulation — stake up 3.5%
💰Trading 88% above estimated fair value — significant premium
Earnings Acceleration Triggers
1. Regulatory Approval Or License Win
OngoingHIGH
2. Value Added Product Mix Shift
Coming quartersMEDIUM
3. Management Or Ownership Change
February 2026MEDIUM
Key Risks
1. Erratic monsoons and flooding changed brine quality and feedstock composition
HIGH2. Increased logistics costs impacted EBITDA margins
MEDIUM3. Lower global crude prices led to slow rig activity, affecting oilfield chemical
MEDIUMSector-Specific Signals
Industrial Salt Sales Volume1.1 million metric tons+38.8%
Elemental Bromine Sales Volume2,403 metric tons-48.7%
Bromine Derivatives Capacity Utilization30% to 40%
Bromine Order Backlog6,500 metric tons
Key Numbers
PAT Growth YoY
-50%
Stable
Revenue YoY
+5%
Stable
Operating Margin
21.0%
-1200 bps YoY
PE Ratio
51.3
Current Price
₹608
Dividend Yield
0.49%
Fundamental Score
32/100
Weak
3Y PAT CAGR
-5%
Market Cap
7.5K Cr
Valuation
Significantly Overvalued12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
Why Are Archean Chemical Industries Ltd's Earnings Accelerating?
Based on Q3 FY26 earnings • Updated Apr 18, 2026
Value Added Product Mix Shift
Expected: Coming quartersMEDIUM confidence
What: Product Pipeline: 15 new products
Impact: 50% to 60% utilization
“We have around 15 new products in pipeline... this should help us, we believe, in total 50% to 60% utilization in the coming quarters.”
Management Or Ownership Change
Expected: February 2026MEDIUM confidence
What: New MD: Rampraveen Swaminathan
“The Board has appointed Mr. Rampraveen Swaminathan as the Managing Director of the company.”
Industrial Salt volumes at 1.1 million tons
MEDIUM confidence
What: Industrial Salt volumes at 1.1 million tons
“On industrial salt, during the quarter, we sold approximately 1.1 million tons of salt, kind of reverting back to our quarterly run rate.”
What Are the Key Risks for Archean Chemical Industries Ltd?
Earnings deceleration risks from management commentary
Erratic monsoons and flooding changed brine quality and feedstock composition
HIGHTrigger: Weather changes led to dilution of bromine concentration in the brine.
Management view: Implementing changes in brine field operations and plant improvements to manage wider feedstock range.
Monitor: climate
Increased logistics costs impacted EBITDA margins
MEDIUMTrigger: Disruptions in the area of operations and higher transport overheads.
Management view: Focusing on recovering cost positions in coming quarters.
Monitor: logistics
Lower global crude prices led to slow rig activity, affecting oilfield chemical
MEDIUMTrigger: Reduced demand for clear brine fluids from oil majors.
Monitor: commodity
What Is Archean Chemical Industries Ltd's Management Saying?
Key quotes from recent conference calls
“While the reported volume is shy below the quarterly guidance of 1 million, we would like to highlight that the shortfall is temporary. [Previous Industrial Salt Volume guidance]”
“And the initial target that was given a 22,000 to 25,000 would this be lower for the next year? [Previous Bromine Production Volume guidance]”
“Our project was among the select few approved by the Union Cabinet under the Indian Semiconductor Mission. [Initiative: SiCSem Semiconductor Project]”
“Our pilot stage trials have been completed successfully... expect meaningful contributions from this business in the -- in F '27. [Initiative: Sulphate of Potash (SOP) Scale-up]”
What Did Archean Chemical Industries Ltd Report This Quarter?
Headline numbers from the latest earnings call
Revenue
₹2,615 million
YoY +10%QoQ +9.2%
Why: Growth was driven by healthy demand in the industrial salt segment and year-on-year growth in derivatives, partially offsetting bromine weakness.
Consolidated revenue grew 10% YoY despite operational challenges in the bromine segment.
EBITDA
₹613.5 million
YoY -27%Margin 23.5%
Why: Margins were compressed by increased logistics costs, new employee expenses, and overheads from new units, alongside lower bromine efficiencies.
EBITDA margins on a standalone basis stood at 27%, impacted by higher logistics and personnel costs.
PAT
₹240 million
QoQ -17.4%
Why: Profitability was impacted by the decline in EBITDA and higher operational costs associated with scaling new units.
Net profit reflects the broader margin pressure seen at the EBITDA level.
Other Highlights
• Industrial salt volumes reverted to 1.1 million tons for the quarter.
• Bromine derivatives utilization reached 30% to 40% range.
• Company remains net debt-free with a robust balance sheet.
What Sector Metrics Matter for Archean Chemical Industries Ltd?
Sub-sector-specific signals from the latest concall — each with management's stated reason for the change
Industrial Salt Sales Volume
1.1 million metric tons
YoY +38.8%QoQ +23.7%
Why: Reverted to normal run rates after monsoon disruptions in Q2.
Elemental Bromine Sales Volume
2,403 metric tons
YoY -48.7%QoQ -23.9%
Why: Constrained by operational challenges and brine quality issues.
Bromine Derivatives Capacity Utilization
30% to 40%
QoQ +5%
Why: Gradual ramp-up and product qualification with end users.
Bromine Order Backlog
6,500 metric tons
QoQ -3,500 tons
Why: Shipped 2,500 tons from the previous 10,000 ton backlog.
Sulphate of Potash (SOP) Capacity
130,000 tons per annum
YoY 0%QoQ 0%
Why: Capacity is installed but awaiting successful plant-scale trials for commercial production.
Semiconductor Project Capex (Phase 1)
₹2,067 crores
YoY NewQoQ 0%
Why: Project approved by Union Cabinet; ground-breaking ceremony conducted.
Bromine Revenue Contribution (Standalone)
23%
YoY -10%QoQ -10%
Why: Lower production volumes and shift in mix towards industrial salt.
Industrial Salt Revenue Contribution (Standalone)
77%
YoY +10%QoQ +10%
Why: Strong volume recovery in the salt segment.
What Is Archean Chemical Industries Ltd's Management Guidance?
Forward-looking targets from management for FY26
Revenue Growth Target
11%
Capex Plan
₹2067 Cr
Revenue Outlook
11% YoY growth for 9M FY26
Capex Plan
₹2,067 crores
SiCSem compound semiconductor project Phase 1
Volume
REAFFIRMED
Management Tone: CAUTIOUS
Guidance Changes
LOWERED
Bromine Production: 22,000-25,000 tons → 18,000 tons (steady state)
How Fast Is Archean Chemical Industries Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +5% | -3% | Stable |
| PAT (Net Profit) | -50% | -5% | Stable |
| OPM | 21.0% | -1200 bps | Volatile |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 18, 2026.
Other Top Chemicals - Inorganic Stocks Beating Nifty 500
Frequently Asked Questions: Archean Chemical Industries Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What were Archean Chemical Industries Ltd's latest quarterly results?
Archean Chemical Industries Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -50.0% (stable)
- Revenue Growth YoY: +5.4%
- Operating Margin: 21.0% (volatile)
Is Archean Chemical Industries Ltd's profit growing or declining?
Archean Chemical Industries Ltd's profit is declining with an stable trend.
- PAT Growth YoY: -50.0% (latest quarter)
- PAT Growth QoQ: -17.2% (sequential)
- 3-Year PAT CAGR: -4.8%
- Trend: Stable — consistent growth pattern
What is Archean Chemical Industries Ltd's revenue growth trend?
Archean Chemical Industries Ltd's revenue growth trend is stable.
- Revenue Growth YoY: +5.4%
- Revenue Growth QoQ: +9.4% (sequential)
- 3-Year Revenue CAGR: -2.7%
How is Archean Chemical Industries Ltd's operating margin trending?
Archean Chemical Industries Ltd's operating margin is volatile.
- Current OPM: 21.0%
- OPM Change YoY: -12.0% basis points
- OPM Change QoQ: -6.0% basis points
What is Archean Chemical Industries Ltd's 3-year profit and revenue CAGR?
Archean Chemical Industries Ltd's long-term compounding rates
- 3-Year Profit CAGR: -4.8%
- 3-Year Revenue CAGR: -2.7%
Is Archean Chemical Industries Ltd's growth accelerating or decelerating?
Archean Chemical Industries Ltd's earnings growth is stable with negative momentum on a sequential basis.
- YoY Acceleration: -131.3% bps
- Sequential Acceleration: +10.3% bps
- Note: YoY and QoQ trends are diverging — worth monitoring
- Margin Warning: Operating margins are under pressure
What is Archean Chemical Industries Ltd's trailing twelve month (TTM) performance?
Archean Chemical Industries Ltd's trailing twelve month (TTM) performance
- TTM PAT: ₹147 Cr
- TTM PAT Growth: -12.0% YoY
- TTM Revenue: ₹1,000 Cr
- TTM Revenue Growth: +15.0% YoY
- TTM Operating Margin: 25.3%
Is Archean Chemical Industries Ltd overvalued or undervalued?
Archean Chemical Industries Ltd appears significantly overvalued based on our fair value analysis.
- Valuation Signal: Significantly Overvalued
- Current PE: 51.3x
- Price-to-Book: 4.0x
What is Archean Chemical Industries Ltd's current PE ratio?
Archean Chemical Industries Ltd's current PE ratio is 51.3x.
- Current PE: 51.3x
- Market Cap: 7.5K Cr
- Dividend Yield: 0.49%
How does Archean Chemical Industries Ltd's valuation compare to its history?
Archean Chemical Industries Ltd's current PE is 51.3x.
- Current PE: 51.3x
- Valuation Assessment: Significantly Overvalued
What is Archean Chemical Industries Ltd's price-to-book ratio?
Archean Chemical Industries Ltd's price-to-book ratio is 4.0x.
- Price-to-Book (P/B): 4.0x
- Book Value per Share: ₹154
- Current Price: ₹608
Is Archean Chemical Industries Ltd a fundamentally strong company?
Archean Chemical Industries Ltd is rated Weak with a fundamental score of 31.9/100. This score is calculated from objective financial metrics
- Revenue Growth YoY: +5.4% (10% weight)
- PAT Growth YoY: -50.0% (10% weight)
- PAT Growth QoQ: -17.2% (10% weight)
- Margins stable (10% weight)
Is Archean Chemical Industries Ltd debt free?
Archean Chemical Industries Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹281 Cr
What is Archean Chemical Industries Ltd's return on equity (ROE) and ROCE?
Archean Chemical Industries Ltd's return ratios over recent years
- FY2023: ROCE 45.0%
- FY2024: ROCE 25.0%
- FY2025: ROCE 13.0%
Is Archean Chemical Industries Ltd's cash flow positive?
Archean Chemical Industries Ltd's operating cash flow is positive (FY2025).
- Cash from Operations (CFO): ₹176 Cr
- Free Cash Flow (FCF): ₹-70 Cr
- CFO/PAT Ratio: 109% (strong cash conversion)
What is Archean Chemical Industries Ltd's dividend yield?
Archean Chemical Industries Ltd's current dividend yield is 0.49%.
- Dividend Yield: 0.49%
- Current Price: ₹608
Who holds Archean Chemical Industries Ltd shares — promoters, FII, DII?
Archean Chemical Industries Ltd's shareholding pattern (Mar 2026)
- Promoters: 53.4%
- FII (Foreign): 11.1%
- DII (Domestic): 25.8%
- Public: 9.7%
Is promoter holding increasing or decreasing in Archean Chemical Industries Ltd?
Archean Chemical Industries Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 53.4% (Mar 2026)
- Previous Quarter: 53.4% (Dec 2025)
- Change: 0.00% (stable)
How long has Archean Chemical Industries Ltd been outperforming Nifty 500?
Archean Chemical Industries Ltd has been outperforming Nifty 500 for 9 consecutive weeks, indicating consistent outperformance.
Is Archean Chemical Industries Ltd a new momentum entry or an established outperformer?
Archean Chemical Industries Ltd is an established outperformer with 9 weeks of consecutive Nifty 500 outperformance.
What are the growth catalysts for Archean Chemical Industries Ltd?
Archean Chemical Industries Ltd has 4 key growth catalysts identified from recent earnings analysis
- Regulatory Approval Or License Win — Approval under the Indian Semiconductor Mission provides fiscal support and strategic positioning.
- Value Added Product Mix Shift — Expanding the bromine derivatives portfolio to improve yields and utilization.
- Management Or Ownership Change — New leadership to drive the next phase of growth and operational excellence.
- Industrial Salt volumes at 1.1 million tons — Recovery from monsoon-related logistics and production disruptions in the previous quarter.
What are the key risks in Archean Chemical Industries Ltd?
Archean Chemical Industries Ltd has 3 key risks worth monitoring
- [HIGH] Erratic monsoons and flooding changed brine quality and feedstock composition — Weather changes led to dilution of bromine concentration in the brine.
- [MEDIUM] Increased logistics costs impacted EBITDA margins — Disruptions in the area of operations and higher transport overheads.
- [MEDIUM] Lower global crude prices led to slow rig activity, affecting oilfield chemical — Reduced demand for clear brine fluids from oil majors.
What did Archean Chemical Industries Ltd's management say in the latest earnings call?
In Q3 FY26, Archean Chemical Industries Ltd's management highlighted
- "While the reported volume is shy below the quarterly guidance of 1 million, we would like to highlight that the shortfall is temporary. [Previous Ind..."
- "And the initial target that was given a 22,000 to 25,000 would this be lower for the next year? [Previous Bromine Production Volume guidance]"
- "Our project was among the select few approved by the Union Cabinet under the Indian Semiconductor Mission. [Initiative: SiCSem Semiconductor Project]"
What is Archean Chemical Industries Ltd's management guidance for growth?
Archean Chemical Industries Ltd's management has provided the following forward guidance for FY26
- Revenue growth target: 11%
- Margin outlook: Not Given
- Capex plan: ₹2067 Cr for SiCSem compound semiconductor project Phase 1
- Management tone: cautious
- Milestone: [LOWERED] Bromine Production: 22,000-25,000 tons → 18,000 tons (steady state)
What sector-specific metrics matter most for Archean Chemical Industries Ltd?
Archean Chemical Industries Ltd's most important sub-sector-specific KPIs from the latest concall
- Industrial Salt Sales Volume: 1.1 million metric tons (YoY +38.8%) (QoQ +23.7%) — Reverted to normal run rates after monsoon disruptions in Q2.
- Elemental Bromine Sales Volume: 2,403 metric tons (YoY -48.7%) (QoQ -23.9%) — Constrained by operational challenges and brine quality issues.
- Bromine Derivatives Capacity Utilization: 30% to 40% (QoQ +5%) — Gradual ramp-up and product qualification with end users.
- Bromine Order Backlog: 6,500 metric tons (QoQ -3,500 tons) — Shipped 2,500 tons from the previous 10,000 ton backlog.
- Sulphate of Potash (SOP) Capacity: 130,000 tons per annum (YoY 0%) (QoQ 0%) — Capacity is installed but awaiting successful plant-scale trials for commercial production.
- Semiconductor Project Capex (Phase 1): ₹2,067 crores (YoY New) (QoQ 0%) — Project approved by Union Cabinet; ground-breaking ceremony conducted.
Is Archean Chemical Industries Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Archean Chemical Industries Ltd may be worth studying
- Cash flow is positive — CFO ₹176 Cr
What is the investment thesis for Archean Chemical Industries Ltd?
Archean Chemical Industries Ltd investment thesis summary:
Research Signals (Bull Case)
- Growth catalyst: Regulatory Approval Or License Win
Risk Factors (Bear Case)
- Margins under pressure
- Appears significantly overvalued
- Key risk: Erratic monsoons and flooding changed brine quality and feedstock composition
What is the future outlook for Archean Chemical Industries Ltd?
Archean Chemical Industries Ltd's forward outlook based on current data signals
- Earnings Trend: stable
- Revenue Trend: stable
- Margin Trend: volatile
- Valuation: Significantly Overvalued
- Key Catalyst: Regulatory Approval Or License Win
- Key Risk: Erratic monsoons and flooding changed brine quality and feedstock composition
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.